Abstract
BackgroundSerotonergic mechanisms play a key role in the development of the Levodopa-induced dyskinesias (LIDs) in patients with Parkinson's disease (PD). We hypothesised that an unfavourable serotonin-to-dopamine terminal ratio in the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have